Page last updated: 2024-09-05

chromazonarol and 2-chloro-n-(4-chlorobiphenyl-2-yl)nicotinamide

chromazonarol has been researched along with 2-chloro-n-(4-chlorobiphenyl-2-yl)nicotinamide in 1 studies

*2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide: an industrial fungicide [MeSH]

*2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide: an industrial fungicide [MeSH]

Compound Research Comparison

Studies
(chromazonarol)
Trials
(chromazonarol)
Recent Studies (post-2010)
(chromazonarol)
Studies
(2-chloro-n-(4-chlorobiphenyl-2-yl)nicotinamide)
Trials
(2-chloro-n-(4-chlorobiphenyl-2-yl)nicotinamide)
Recent Studies (post-2010) (2-chloro-n-(4-chlorobiphenyl-2-yl)nicotinamide)
70216014

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Hu, N; Kong, W; Li, S; Song, B; Wang, X1

Other Studies

1 other study(ies) available for chromazonarol and 2-chloro-n-(4-chlorobiphenyl-2-yl)nicotinamide

ArticleYear
Facile and divergent optimization of chromazonarol enabled the identification of simplified drimane meroterpenoids as novel pharmaceutical leads.
    European journal of medicinal chemistry, 2022, Jan-05, Volume: 227

    Topics: Antifungal Agents; Ascomycota; Dose-Response Relationship, Drug; Fusarium; Humans; Microbial Sensitivity Tests; Molecular Structure; Rhizoctonia; Stereoisomerism; Structure-Activity Relationship; Xanthenes

2022